Connectivity Alterations After Levetiracetam Application

Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

NCT07336992 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

NCT00415376 ·Status: WITHDRAWN ·Phase: NA

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

NCT06866691 ·Status: RECRUITING ·Phase: PHASE4

Levetiracetam Prophylaxis in Brain Tumor Resection Pilot

NCT05897658 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

NCT01506882 ·Status: COMPLETED ·Phase: PHASE3

The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study

NCT02208492 ·Status: COMPLETED ·Phase: PHASE4

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

NCT03940326 ·Status: COMPLETED ·Phase: PHASE4

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

NCT01228747 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

NCT00430599 ·Status: COMPLETED

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

NCT00160628 ·Status: COMPLETED ·Phase: PHASE3

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

NCT03054285 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy

NCT06491303 ·Status: NOT_YET_RECRUITING

Prevention of Post-traumatic Seizures With Levetiracetam

NCT00566046 ·Status: TERMINATED ·Phase: PHASE3

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

NCT06393309 ·Status: COMPLETED

Levetiracetam to Prevent Post-Traumatic Epilepsy

NCT01463033 ·Status: COMPLETED ·Phase: PHASE2

Treating Hyperexcitability in AD With Levetiracetam

NCT03875638 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

NCT01392768 ·Status: COMPLETED ·Phase: PHASE3

Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

NCT02002819 ·Status: COMPLETED ·Phase: PHASE2

Short Versus Long-term Levetiracetam in Brain Tumors

NCT06442748 ·Status: RECRUITING ·Phase: PHASE3

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

NCT06081283 ·Status: TERMINATED ·Phase: PHASE4

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy

NCT01498822 ·Status: COMPLETED ·Phase: PHASE4

Generic Substitution of Original Levetiracetam in Thai Epilepsy Patients

NCT04132063 ·Status: COMPLETED

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

NCT00160654 ·Status: COMPLETED ·Phase: PHASE4

Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

NCT02815410 ·Status: UNKNOWN ·Phase: PHASE2

Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy

NCT05969054 ·Status: RECRUITING ·Phase: PHASE4